ArticleCancer immunology research2020

Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models.

Yasuhiro Maruoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.